Form 4: Cerus Corp Executive Richard J. Benjamin Reports Stock Sales

Chief Medical Officer Richard J. Benjamin of Cerus Corp reports the sale of common stock to cover tax obligations and pursuant to a 10b5-1 trading plan.

Summary

• Richard J. Benjamin, Chief Medical Officer of Cerus Corporation, filed a Form 4 detailing changes in beneficial ownership.
• On March 3, 2025, Benjamin sold 51,254 shares of common stock at a weighted average price of $1.577 per share, ranging from $1.525 to $1.67.
• On March 3, 2025, 13,912 restricted stock units were converted to common stock.
• On March 4, 2025, Benjamin sold 6,292 shares at a weighted average price of $1.5485 per share, ranging from $1.49 to $1.59.
• These sales were executed to cover tax withholding obligations and brokerage fees related to the vesting of restricted stock units and pursuant to a pre-arranged 10b5-1 trading plan.
• Following these transactions, Benjamin directly owns 394,373 shares of Cerus common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reflects routine transactions related to tax obligations and a pre-arranged trading plan, with no indication of unusual or concerning activity.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The stock sales by a company insider could have a minor negative impact on shareholder sentiment, but the impact is likely to be minimal given the routine nature of the transactions.

Key Dates